Tiziana Life Sciences PLC
Anti-CD3 antibody formulations
Last updated:
Abstract:
This invention relates to therapeutic, diagnostic and/or prophylactic formulations and dosages and dosing regimens of anti-CD3 antibodies, as well as to methods for using such formulations and dosages and dosing regimens.
Status:
Grant
Type:
Utility
Filling date:
29 Aug 2017
Issue date:
23 Jun 2020